Abstract:The onset of obesity-linked type 2 diabetes (T2D) is marked by an eventual failure in pancreatic β-cell function and mass that is no longer able to compensate for the inherent insulin resistance and increased metabolic load intrinsic to obesity. However, in a commonly used model of T2D, the db/db mouse, β-cells have an inbuilt adaptive flexibility enabling them to effectively adjust insulin production rates relative to the metabolic demand. Pancreatic β-cells from these animals have markedly reduced intracellular insulin stores, yet high rates of (pro)insulin secretion, together with a substantial increase in proinsulin biosynthesis highlighted by expanded rough endoplasmic reticulum and Golgi apparatus. However, when the metabolic overload and/or hyperglycemia is normalized, β-cells from db/db mice quickly restore their insulin stores and normalize secretory function. This demonstrates the β-cell's adaptive flexibility and indicates that therapeutic approaches applied to encourage β-cell rest are capable of restoring endogenous β-cell function. However, mechanisms that regulate β-cell adaptive flexibility are essentially unknown. To gain deeper mechanistic insight into the molecular events underlying β-cell adaptive flexibility in db/db β-cells, we conducted a combined proteomic and post-translational modification specific proteomic (PTMomics) approach on islets from db/db mice and wild-type controls (WT) with or without prior exposure to normal glucose levels. We identified differential modifications of proteins involved in redox homeostasis, protein refolding, K48-linked deubiquitination, mRNA/protein export, focal adhesion, ERK1/2 signaling, and renin-angiotensin-aldosterone signaling, as well as sialyltransferase activity, associated with β-cell adaptive flexibility. These proteins are all related to proinsulin biosynthesis and processing, maturation of insulin secretory granules, and vesicular trafficking-core pathways involved in the adaptation of insulin production to meet metabolic demand. Collectively, this study outlines a novel and comprehensive global PTMome signaling map that highlights important molecular mechanisms related to the adaptive flexibility of β-cell function, providing improved insight into disease pathogenesis of T2D.

Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic β-cells

Coordinated Regulation By Shp2 Tyrosine Phosphatase Of Signaling Events Controlling Insulin Biosynthesis In Pancreatic Beta-Cells

Coordinated Regulation by Shp2 Tyrosine Phosphatase of Signaling Events Controlling Insulin Biosynthesis in Β‐cells

SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice

SH2B1 in Β-Cells Regulates Glucose Metabolism by Promoting Β-Cell Survival and Islet Expansion.

Irtks Promotes Insulin Signaling Transduction Through Inhibiting Ship2 Phosphatase Activity

Dual Function of PI(4,5)P2 in Insulin-Regulated Exocytic Trafficking of GLUT4 in Adipocytes

The PI(4)P phosphatase Sac2 controls insulin granule docking and release

Signal transduction pathways controlling Ins2 gene activity and β cell state transitions

Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes

Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1

Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance

Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2

Absence of Shb impairs insulin secretion by elevated FAK activity in pancreatic islets.

Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase.

The Transcriptional Co-Regulator HCF-1 is Required for INS-1 Β-Cell Glucose-Stimulated Insulin Secretion

Unraveling the significance of PPP1R1A gene in pancreatic β-cell function: A study in INS-1 cells and human pancreatic islets

IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion

Modulation of Fatty Acid Synthase Degradation by Concerted Action of P38 MAP Kinase, E3 Ligase COP1, and SH2-Tyrosine Phosphatase Shp2*

Nonreceptor Tyrosine Phosphatase Shp2 Promotes Adipogenesis Through Inhibition of P38 MAP Kinase.

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice